Related Experiment Video
Updated: Aug 14, 2026

Ex Vivo Organotypic Corneal Model of Acute Epithelial Herpes Simplex Virus Type I Infection
Published on: November 3, 2012
Long-term oral acyclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and
1Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston 02114, USA.
Purpose:
To evaluate the efficacy of long-term oral acyclovir therapy in reducing recurrences of dendritic or geographic herpes simplex keratitis (HSK).
Methods:
Thirteen patients with a history of frequently recurring HSK were followed before (mean, 27 months) and during long-term systemic acyclovir, and eight were followed after the acyclovir was discontinued.
Results:
Treatment ranged from 8.5 to 62 months (mean, 34 months). During treatment, the number of recurrences per month decreased from 0.15 to 0.03, and the average duration of relapses decreased from 12.6 to 7.8 days. Recurrences correlated with daily doses of oral acyclovir of 800 mg or less, intraocular surgery within 6 weeks of initiating treatment, and discontinuation of therapy against medical advice.
Conclusion:
The results of this small study appear to demonstrate the efficacy of long-term oral acyclovir in prophylaxis of recurrent epithelial herpes simplex infection: therapeutic doses of oral acyclovir reduce both the rate and duration of recurrences of infectious herpetic keratitis. A multicenter, double-masked, placebo-controlled study is indicated.
Insights
Long-term oral acyclovir effectively reduces herpes simplex keratitis (HSK) recurrences. This treatment lowers both the frequency and duration of infectious herpetic keratitis relapses, proving beneficial for patients.
Area of Science:
- Ophthalmology
- Virology
- Pharmacology
Background:
- Herpes simplex keratitis (HSK) is a recurrent viral infection of the cornea.
- Frequent recurrences can lead to vision loss and significant morbidity.
- Prophylactic treatment strategies are crucial for managing chronic HSK.
Purpose of the Study:
- To assess the effectiveness of long-term oral acyclovir in preventing recurrent herpes simplex keratitis (HSK).
- To evaluate the impact of acyclovir on the rate and duration of HSK recurrences.
Main Methods:
- A retrospective study of 13 patients with a history of recurrent HSK.
- Patients were monitored before, during, and after long-term systemic acyclovir therapy.
- Recurrence data and treatment parameters were analyzed.
Main Results:
- Oral acyclovir significantly reduced the monthly recurrence rate of HSK (from 0.15 to 0.03).
- The average duration of HSK relapses decreased from 12.6 to 7.8 days during treatment.
- Lower acyclovir doses (≤800 mg/day), recent intraocular surgery, and therapy discontinuation were associated with recurrences.
Conclusions:
- Long-term oral acyclovir demonstrates efficacy in preventing epithelial herpes simplex virus infections.
- Therapeutic acyclovir doses effectively reduce both the incidence and duration of herpetic keratitis recurrences.
- Further investigation via a multicenter, double-masked, placebo-controlled trial is recommended.
Related Concept Videos
DNA Base Pairing
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Herpes
Genital Herpes

